# A Cohort Study of the Efficacy and Safety of Biologics in Patients With ABPA

> **NCT07362693** · — · RECRUITING · sponsor: **Qianfoshan Hospital** · enrollment: 50 (estimated)

## Conditions studied

- ABPA
- Biologics
- Allergic Bronchopulmonary Aspergillosis (ABPA)
- Cohort Study
- Allergic Bronchopulmonary Aspergillosis
- Efficacy and Safety

## Interventions

- **DRUG:** Biologic Agent

## Key facts

- **NCT ID:** NCT07362693
- **Lead sponsor:** Qianfoshan Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-01-31
- **Primary completion:** 2028-12-31
- **Final completion:** 2028-12-31
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2026-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07362693

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07362693, "A Cohort Study of the Efficacy and Safety of Biologics in Patients With ABPA". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07362693. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*